BAMCO Inc’s CVS Health CVS Stock Holding History

BAMCO Inc’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,000	Closed	-$980K	–	334
2025 Q3	$980K	Buy	+13,000	New	+$891K	﹤0.01%	303

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc's CVS Position: Q4 2025 in Review

BAMCO Inc sold out of CVS Health (CVS) in Q4 2025, closing a stake of 13,000 shares — an estimated $980K sold.

BAMCO Inc first reported a position in CVS in Q3 2025 and held it in 1 quarter. The position peaked at $980K in Q3 2025. 1,952 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

BAMCO Inc reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
BAMCO Inc sold 13,000 CVS Health shares in Q4 2025, an estimated $980K.
BAMCO Inc first reported a position in CVS Health in Q3 2025 and held it in 1 quarter.
BAMCO Inc's CVS Health position peaked at $980K in Q3 2025.
1,952 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on BAMCO Inc's 13F filing for Q4 2025, filed 17 Feb 2026.